9 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
policies that will spur future mRNA breakthroughs.
Awards and Recognitions:
Cygnus Technologies received a 2023 R&D 100 Award from R&D World
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
, managing complex R&D programs, driving global commercial initiatives, and executing strategic acquisitions. Additionally, he has a stellar reputation
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
5 May 22
Maravai Lifesciences Reports First Quarter 2022 Financial Results
12:00am
, our expectations for superior growth and profitability; our ability to make investments in R&D, capacity and people; our predictions regarding demand
8-K
EX-99.1
si29euji1ez3ws 9ru
23 Feb 22
Maravai Lifesciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
4:08pm
8-K
EX-99.1
blw9pwjhs
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-99.1
ulk3v
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-K
2xor1n4
22 Mar 21
Annual report
4:22pm
- Prev
- 1
- Next